Table 2 Position of LV lead
From: Galectin-3 predicts response and outcomes after cardiac resynchronization therapy
Basal (N = 32) | Mid (N = 21) | Apical (N = 8) | |
|---|---|---|---|
Antero-lateral (N = 27) | 20 (33%) | 7 (11%) | 0 |
Lateral (N = 27) | 12 (20%) | 12 (20%) | 3 (5%) |
Infero-lateral (N = 7) | 0 | 2 (3%) | 5 (8%) |